Reduction of pain and EMG activity in the masseter region by trapezius trigger point injection.
In this open, uncontrolled trial, 20 patients with upper trapezius muscle trigger point pain and ipsilateral masseter muscle pain received a single trigger point injection of 2% lidocaine solution (without epinephrine) in the upper trapezius muscle. Following the trapezius injection, there was a significant (P < 0.001) reduction in pain intensity ratings for pain in the masseter region. In addition, there was a significant (P < 0.03) reduction in EMG activity in the masseter muscle. Overall, however, a significant relationship between EMG activity in the masseter and the self-report of pain was not found with the present data set. These clinical findings support the contention that sources of deep pain can produce heterotopic sensory and motor changes in distant anatomical regions.
Carlson
Chrles R
CR
Department of Psychology and the Orofacial Pain Center, College of Dentistry, University of Kentucky, Lexington, KY 40536 USA.
Okeson
Jeffrey P
JP
Falace
Donald A
DA
Nitz
Arthur J
AJ
Lindroth
John E
JE
D000293:Adolescent; D000328:Adult; D004576:Electromyography; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008012:Lidocaine / Q000008:administration & dosage / Q000627:therapeutic use*; D008406:Masseter Muscle / Q000503:physiopathology; D008875:Middle Aged; D009209:Myofascial Pain Syndromes / Q000188:drug therapy* / Q000503:physiopathology; D010146:Pain / Q000188:drug therapy* / Q000503:physiopathology
D008012:Lidocaine